Etiqueta: stem cells
-
BioTime Receives Second Round of Funding
The embryonic stem cell company BioTime receives $4 million in its second equity tranche.
-
NIH received varied responses, some poignant, on stem-cell draft
There were approximately 49,000 comments sent into the NIH in response to a publicly available draft of the new guidelines to embryonic stem cell research.
-
New Technology Breakthroughs Showcased at Annual Stem Cell Conference
New advances in instrumentation and laboratory technology are featured at this year’s ISSCR conference in Barcelona.
-
BioTime Announces Agreement With Millipore
BioTime’s subsidiary, Embryome Sciences, enters into a co-marketing agreement with Millipore.
-
Cellular Dynamics Creates iPS Cells From Human Blood
Cellular Dynamics International announces a new breakthrough with iPS cells, having created the cells from human blood.
-
High School Coach Heads to Central America for Adult Stem Cell Therapy
Yet another American bravely decides to travel overseas for adult stem cell therapy that was pioneered by U.S. doctors but which is not available in the United States.
-
New Director of NIH Chosen
President Obama nominates the former director of The Human Genome Project, Dr. Francis Collins, as the new director of the National Institutes of Health.
-
Boston’s biotech community leads wave of stem cell consolidation, deal making
Merger of IZumi Bio and Pierian Inc was announced, with the new company being named IPierian.
-
Can Stem Cells Become Sperm Cells?
Researchers in England announce the creation of human sperm from embryonic stem cells.